{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T10:58:55Z","timestamp":1753354735207},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1097\/01.coc.0000037109.12434.52","type":"journal-article","created":{"date-parts":[[2003,10,6]],"date-time":"2003-10-06T08:02:51Z","timestamp":1065427371000},"page":"477-482","source":"Crossref","is-referenced-by-count":15,"title":["Docetaxel as Neoadjuvant Chemotherapy in Patients With Advanced Cervical Carcinoma"],"prefix":"10.1097","volume":"26","author":[{"given":"Carlos T.","family":"Vallejo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario R.","family":"Machiavelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan E.","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto O.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrina","family":"Bologna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hern\u00e1n","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan A.","family":"Lacava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo H.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Cubero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Focaccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Suttora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirna","family":"Scenna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Boughen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo A.","family":"Leone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210128","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ijc.2910540413","article-title":"Estimates of the worldwide incidence of eighteen major cancers in 1985","volume":"54","author":"Parkin","year":"1993","journal-title":"Int J Cancer"},{"key":"R2-9-20210128","first-page":"16","article-title":"Chemotherapy as a palliative treatment in carcinoma of the uterine cervix","volume":"22","author":"Thigpen","year":"1995","journal-title":"Semin Oncol"},{"key":"R4-9-20210128","first-page":"507","article-title":"Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma","volume":"46","author":"Piver","year":"1975","journal-title":"Obstet Gynecol"},{"key":"R5-9-20210128","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0090-8258(89)90029-2","article-title":"Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix","volume":"36","author":"Alvarez","year":"1989","journal-title":"Gynecol Oncol"},{"key":"R6-9-20210128","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0090-8258(90)90072-S","article-title":"Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study","volume":"38","author":"Delgado","year":"1990","journal-title":"Gynecol Oncol"},{"key":"R7-9-20210128","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0360-3016(94)00523-0","article-title":"Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update of a nonrandomized comparison","volume":"31","author":"P\u00e9rez","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R8-9-20210128","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2214\/ajr.106.4.831","article-title":"Analysis of central recurrent disease in stages I and II squamous cell carcinomas of the cervix on intact uterus","volume":"106","author":"Durrance","year":"1969","journal-title":"AJR Radium Ther Nucl Med"},{"key":"R9-9-20210128","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/1097-0142(19850715)56:2<262::AID-CNCR2820560210>3.0.CO;2-A","article-title":"Combined radiation therapy and extra-fascial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer","volume":"56","author":"Gallion","year":"1985","journal-title":"Cancer"},{"key":"R10-9-20210128","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/1097-0142(197607)38:1<596::AID-CNCR2820380184>3.0.CO;2-C","article-title":"Clinical studies with adjunctive surgery and irradiation therapy in the treatment of carcinoma of the cervix","volume":"38","author":"Rutledge","year":"1976","journal-title":"Cancer"},{"key":"R11-9-20210128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0305-7372(79)80057-2","article-title":"Cisplatin (cis-diammine dichloroplatinum II)","volume":"6","author":"Prestayko","year":"1979","journal-title":"Cancer Treat Rev"},{"key":"R12-9-20210128","first-page":"1005","article-title":"Chemotherapy for advanced cervical cancer with bleomycin, vincristine, mitomycin C, and cis-diammine dichloroplatinum (II) (BOMP)","volume":"64","author":"Vogl","year":"1980","journal-title":"Cancer Treat Rep"},{"key":"R13-9-20210128","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.1999.17.5.1339","article-title":"Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group study","volume":"17","author":"Whitney","year":"1999","journal-title":"J Clin Oncol"},{"key":"R14-9-20210128","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","article-title":"Cisplatin radiation and adjuvant hysterectomy for bulky stage Ib cervical carcinoma","volume":"340","author":"Keys","year":"1999","journal-title":"N Engl J Med"},{"key":"R15-9-20210128","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","article-title":"Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer","volume":"340","author":"Morris","year":"1999","journal-title":"N Engl J Med"},{"key":"R16-9-20210128","article-title":"Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high-risk, early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy [Abstract]","volume":"28","author":"Peters","year":"1999","journal-title":"Proc Soc Gynecol Oncol"},{"key":"R17-9-20210128","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based chemotherapy and radiotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N Engl J Med"},{"key":"R18-9-20210128","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1200\/JCO.1999.17.5.1334","article-title":"Concurrent chemotherapy and radiation: a major advance for women with cervical cancer [Editorial]","volume":"17","author":"Eifel","year":"1999","journal-title":"J Clin Oncol"},{"key":"R19-9-20210128","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.1021\/ja00225a063","article-title":"A highly efficient practical approach to natural Taxol","volume":"110","author":"Denis","year":"1988","journal-title":"J Am Chem Soc"},{"key":"R20-9-20210128","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1016\/S0040-4020(01)81313-2","article-title":"Application of the vicinal oxyamination reaction with asymmetric induction to the hemisynthesis of Taxol and analogues","volume":"45","author":"Mangatal","year":"1989","journal-title":"Tetrahedron"},{"key":"R21-9-20210128","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/277665a0","article-title":"Promotion of microtubule assembly in vitro by Taxol","volume":"277","author":"Schiff","year":"1979","journal-title":"Nature"},{"key":"R22-9-20210128","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1021\/jm00107a017","article-title":"Relationships between the structure of Taxol analogues and their antimitotic activity","volume":"34","author":"Gueritte-Voegelein","year":"1991","journal-title":"J Med Chem"},{"key":"R23-9-20210128","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jnci\/83.4.288","article-title":"Studies with RP 56976 (Taxotere): a semisynthetic analogue of Taxol","volume":"83","author":"Ringel","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"R24-9-20210128","first-page":"526","article-title":"Responses of human tumor xenografts to Taxotere [Abstract]","volume":"33","author":"Harrison","year":"1992","journal-title":"Proc Am Assoc Cancer Res"},{"key":"R25-9-20210128","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0360-3016(92)90382-R","article-title":"Synergistic effects of Taxol Taxotere on radiation sensitivity on human tumor cell lines","volume":"24","author":"Choy","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R26-9-20210128","first-page":"526","article-title":"Responses of human tumor xenografts to Taxotere [Abstract]","volume":"33","author":"Harrison","year":"1992","journal-title":"Proc Am Assoc Cancer Res"},{"key":"R27-9-20210128","first-page":"A963","article-title":"Docetaxel-based combined modality therapy for locally advanced carcinoma of the esophagus and gastric cardia [Abstract]","volume":"18","author":"Mauer","year":"1999","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"R28-9-20210128","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1200\/JCO.1995.13.3.645","article-title":"Phase II study of docetaxel for advanced or metastatic platinum refractory non-small cell lung cancer","volume":"1","author":"Fosella","year":"1995","journal-title":"J Clin Oncol"},{"key":"R29-9-20210128","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1200\/JCO.1996.14.5.1672","article-title":"Docetaxel: an active drug for squamous cell carcinoma of the head and neck","volume":"14","author":"Dreyfus","year":"1996","journal-title":"J Clin Oncol"},{"key":"R30-9-20210128","first-page":"1037","article-title":"Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion","volume":"53","author":"Extra","year":"1993","journal-title":"Cancer Res"},{"key":"R31-9-20210128","first-page":"523","article-title":"Phase I and pharmacokinetic study of Taxotere (RP 56976) administered as a 24-hour infusion","volume":"53","author":"Bisset","year":"1993","journal-title":"Cancer Res"},{"key":"R32-9-20210128","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/jnci\/84.23.1781","article-title":"Phase I trial of taxotere: five-day schedule","volume":"84","author":"Pazdur","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"R33-9-20210128","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1200\/JCO.1993.11.5.950","article-title":"Phase I clinical trial of taxotere given as either a 2-hour or a 6-hour intravenous infusion","volume":"11","author":"Burris","year":"1993","journal-title":"J Clin Oncol"},{"key":"R34-9-20210128","first-page":"261","article-title":"Phase I pharmacokinetic study of Taxotere (RP 56976) administered as a weekly infusion [Abstract]","volume":"33","author":"DeValeriola","year":"1992","journal-title":"Proc Am Assoc Cancer Res"},{"key":"R35-9-20210128","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"R36-9-20210128","first-page":"265","article-title":"Five classes of extended hysterectomy for women with cervical cancer","volume":"44","author":"Piver","year":"1974","journal-title":"Obstet Gynecol"},{"key":"R38-9-20210128","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"R39-9-20210128","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1200\/JCO.1985.3.10.1418","article-title":"Exploratory data analysis and the use of the hazard function for interpreting survival data: an investigator\u2019s primer","volume":"3","author":"Simes","year":"1985","journal-title":"J Clin Oncol"},{"key":"R40-9-20210128","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1200\/JCO.1984.2.11.1281","article-title":"The importance of dose intensity in chemotherapy of metastatic breast cancer","volume":"2","author":"Hryniuk","year":"1984","journal-title":"J Clin Oncol"},{"key":"R41-9-20210128","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00000421-200010000-00010","article-title":"Neoadjuvant chemotherapy with ifosfamide, cisplatin and vinorelbine in advanced squamous cell carcinoma of the cervix","volume":"23","author":"Vallejo","year":"2000","journal-title":"Am J Clin Oncol"},{"key":"R42-9-20210128","first-page":"2471","article-title":"Phase II clinical study of RP56976 (docetaxel) in patients with carcinoma ovarii or carcinoma colli uteri","volume":"21","author":"Noda","year":"1994","journal-title":"Gan To Kagaku Ryoko"},{"key":"R43-9-20210128","first-page":"A800","article-title":"Advanced squamous cell cancer of the cervix: a phase II study of docetaxel (taxotere) 100 mg\/m2intravenously over 1 hr every 21 days: a preliminary report [Abstract]","volume":"15","author":"Levy","year":"1996","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"R44-9-20210128","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00000421-200204000-00010","article-title":"Phase I\/II trial of outpatient docetaxel, cisplatin, 5-fluororacil, leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN)","volume":"25","author":"Colevas","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"R45-9-20210128","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1200\/JCO.2002.20.2.420","article-title":"Temozolomide in combination with docetaxel in patients with advanced melanoma: a phase II study of the Hellenic Cooperative Oncology Group","volume":"20","author":"Bafaloukos","year":"2002","journal-title":"J Clin Oncol"},{"key":"R46-9-20210128","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/cncr.2820710408","article-title":"New approaches to high-risk cervical cancer. Advanced cervical cancer","volume":"71","author":"Jones","year":"1993","journal-title":"Cancer"},{"key":"R47-9-20210128","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1200\/JCO.1997.15.2.604","article-title":"Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma","volume":"15","author":"Lacava","year":"1997","journal-title":"J Clin Oncol"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.coc.0000037109.12434.52","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:19:50Z","timestamp":1620937190000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-200310000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003]]}},"URL":"https:\/\/doi.org\/10.1097\/01.coc.0000037109.12434.52","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}